Try our Advanced Search for more refined results

July 07, 2016

BURLESON v. LIPOCINE INC. et al

Track this case

Case Number:

3:16-cv-04129

Court:

New Jersey

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Brian R. Martinotti

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. July 11, 2016

    Lipocine Lied About Testosterone Pill's Chances, Investors Say

    Lipocine Inc. misled investors by saying the U.S. Food and Drug Administration cleared its new testosterone drug when in fact the agency identified issues with the labeling, causing stock values to plummet, according to a putative class action filed in New Jersey federal court Friday.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login